Biotech Rally and Bitcoin Surge Shake Up AI Stocks

Daily Financial Update

Opening Recap

• Market Pulse → Tech sector drifts as requests to slow AI gains weigh on Nvidia and Intel, but Bitcoin climbed past recent highs on renewed digital gold narratives.

• Key Movers → “Bitcoin Climbs as AI Slowdown Calls Sink Nvidia, Intel and Other Chip Stocks” and dual earnings beats from Fluor (“Fluor Shares Rise 6.1% Following Earnings Beat and Analyst Actions”) shifted flows, while biotech’s surge saw Scholar Rock and Curium crack open new FDA approvals.

• Macro & Politics → FDA’s accelerated nod for ISEMBYLD and BEXLUTRY shows Washington easing its grip on rare disease drugs, though policymakers remain under scrutiny for any lingering red tape.

• What’s Next → Eyes pivot to AI chip demand updates and potential M&A chatter in biotech as FDA activity fuels sector rotations.

Market Commentary

Everyone’s ignoring that winning FDA clearances for BEXLUTRY (Curium™ announces FDA approval of BEXLUTRY lutetium Lu 177 dotatate injection for adults with SSTR-positive GEP-NETs, Financial Post) and ISEMBYLD (Scholar Rock’s muscle-targeting SMA therapy Isemblyd lands FDA approval, Biztoc.com) isn’t just a green light for sales—it’s a damn complex manufacturing marathon. Radioligand therapies need specialized supply chains and pricey production facilities: one hiccup could derail expected revenue flows faster than any disappointing earnings report.

When AI chatter over capacity limits knocks Nvidia and Intel off their pedestals (Decrypt’s “Bitcoin Climbs as AI Slowdown Calls Sink Nvidia, Intel and Other Chip Stocks”), cash-rich upstarts like Serve Robotics (Barchart.com’s “Wonder Deal, $240M Cash, and 31% Short Interest. A Short Squeeze Could Be Brewing in Serve Robotics Stock.”) are lurking under the radar. It’s wild how the same skepticism that sends chips tumbling can ignite a short-squeeze bonanza elsewhere—proof that elbow room in tech markets shifts in a blink.

Don’t sit still: skim 24/7 Wall St.’s “Forget Nvidia. Apple Could Be the AI Stock to Watch Next” for off-the-radar upside, follow Curium’s and Scholar Rock’s progress on BEXLUTRY and ISEMBYLD for catalyst-driven spikes, and watch short-interest chatter around Serve Robotics. Be ready to pull triggers at the first sign of a biotech bid or a crypto breakout.